SEC Form 4 · accession 0001628280-17-011463
CHAMPIONS ONCOLOGY, INC. · CSBR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip P. Breitfeld
Director
Period of report
Nov 8, 2017
Accepted (ET)
Nov 13, 2017 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000771856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common StockF1 | $3.21 | Nov 8, 2017 | A | 8,333 | A | — | Oct 31, 2022 | Common Stock | 8,333 | 8,333 | D |
Explanation of responses
- F1The options vest and are exercisable over a twelve month period, with vesting to occur on November 8, 2017, February 1, 2018, May 1, 2018 and August 1, 2018, respectively.